Aciont Inc.

AciontTM Inc. endeavors to become the world leader in commercializing localized, non-invasive and controlled release back-of-the-eye therapeutics for sight threatening diseases. Our name Aciont ("action transport therapeutics") refers to our expertise in controlling drug transport through human membrane tissues. Our Visulex TM technology provides ophthalmologists (and potentially patients themselves) substantially greater freedom in treating and/or preventing chronic eye diseases through superior drug dosing control and improved patient compliance. Internal product development focus areas address unmet medical needs in age related macular degeneration, diabetic retinopathy, chronic macular edema, and posterior uveitis. The back-of-the-eye therapeutics market represents more than $6 billion in potential sales in the United States and European countries. The following provides additional information relating to who we are and our business.

Contact Details: 350 West 800 North, Suite 320 Salt Lake City Utah 84103 United States of America Tel: 801-359-3461 Fax: 801-359-3464 Email: admin@aciont.com WWW: www.aciont.com/

Loading...

BioNews Results for Aciont Inc.:
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	Montana's News Station:  Aug 31 2008 2:04PM Matching: inc
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	KSLA:  Aug 30 2008 3:44PM Matching: inc
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	KRON4:  Aug 30 2008 11:18AM Matching: inc
Biotechs Ahead of Pharma in '08 New Drug Approvals	Macro World Investor:  Aug 29 2008 11:23PM Matching: inc
Biotechs Ahead of Pharma in '08 New Drug Approvals	Calibre Macro World:  Aug 29 2008 10:55PM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Aciont Inc. news.

Aciont Inc. Patents:
US Patent No.	Title
7137975	Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent
6801804	Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
6553255	Use of background electrolytes to minimize flux variability during iontophoresis

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 287 times since April 2007, the link to the organisation's website has been followed 54 times

Recent Search Terms used to find this page: visulex aciont 2008 | Aciont Inc. | aciont | Aciont | Aciont Inc | Aciont Inc. | Aciont Inc | aciont | Visulex iontophoresis | Aciont | .

Search for more companies in Salt Lake City

Search for more companies in Utah

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Aciont Inc.